Widening the Therapeutic Index & Overcoming the Negative Class Effects of GLP Drugs Through Incretin Combination Therapy
Time: 1:00 pm
day: Conference Day One
Details:
- Complementary GLP treatment approaches to minimise adverse reactions
- Demonstrating the potential of CCK mediated gut-brain signalling for safe, effective, and additive treatment for obesity and other indications
- Hunger vs appetite and selection of optimal therapeutic modalities